首页> 外文期刊>Journal of voice: official journal of the Voice Foundation >Missed opportunity for larynx preservation? Failure to distinguish verrucous and squamous cell carcinoma on microlaryngoscopy and biopsy.
【24h】

Missed opportunity for larynx preservation? Failure to distinguish verrucous and squamous cell carcinoma on microlaryngoscopy and biopsy.

机译:错过了喉部保存的机会? 未能区分疣状和鳞状细胞癌对微淋镜检查和活组织检查。

获取原文
获取原文并翻译 | 示例
       

摘要

The current standard for stage III and selected stage IV squamous cell carcinoma of the larynx includes organ sparing concurrent chemoradiation therapy. Verrucous carcinoma is predominantly treated with surgery, including laryngectomy in selected cases. Expert and appropriate pathologic interpretation of verrucous carcinoma with an ample biopsy specimen of the larynx using microlaryngoscopy can differ from the final pathology (squamous cell carcinoma) in a laryngectomy specimen. This can potentially lead to a failed opportunity for larynx preservation. A 68-year-old African-American male presented with a chief complaint of airway obstruction from a massive obstructing laryngeal tumor. This patient was initially treated with operative microlaryngoscopy and debulking of the laryngeal neoplasm. Computed tomography scan was not interpreted for cartilaginous invasion. Final pathological interpretation of this microlaryngoscopy and biopsy specimen included an "outside the institution" expert second opinion and that interpretation was consistent with verrucous carcinoma. Multidisciplinary head and neck oncology team recommendation was total laryngectomy. Final pathology report of the laryngectomy specimen revealed squamous cell carcinoma with extension through cartilage and anterior soft tissue extension. Expert and appropriate interpretation of an ample biopsy specimen by microlaryngoscopy can result in failure to distinguish verrucous from squamous cell carcinoma, potentially leading to missed opportunities for larynx preservation. In this case, cartilage invasion of a massive larynx squamous cell carcinoma made laryngectomy a reasonable therapeutic option.
机译:液位III阶段和所选阶段IV鳞状细胞癌的目前标准包括器官备受同时的化学疗法。疣状癌主要用手术治疗,包括选定病例中的喉切除术。使用微淋镜检查的喉癌具有充足的活组织检查的疣状癌的专家和适当的病理解释可以与喉切除术样标本中的最终病理(鳞状细胞癌)不同。这可能导致喉部保存失败的机会。一名68岁的非洲裔美国男性展示了一种来自巨大的阻塞喉肿瘤的气道阻塞的主要抱怨。该患者最初用手术微淋镜检查和喉肿瘤的剥离处理。计算断层扫描扫描不是对软骨侵袭解释的。这种微淋镜检查和活检标本的最终病理解释包括“机构之外”专家第二意见,并将解释与Verrucous癌一致。多学科头部和颈部肿瘤学团队推荐总喉部切除术。喉切除术标本的最终病理报告显示通过软骨和前部软组织延伸的延伸鳞状细胞癌。专家和适当地解释微肠镜检查检查的富含活组织检查标本可能导致未能区分鳞状细胞癌,可能导致错过喉部保存的机会。在这种情况下,软骨侵袭巨大的喉鳞状细胞癌使喉切除术治疗选择性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号